Chlorpheniramine polistirex; codeine polistirex - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for chlorpheniramine polistirex; codeine polistirex and what is the scope of freedom to operate?
Chlorpheniramine polistirex; codeine polistirex
is the generic ingredient in three branded drugs marketed by Lannett Co Inc, Fisons, and Tris Pharma Inc, and is included in three NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Chlorpheniramine polistirex; codeine polistirex has twenty-one patent family members in fourteen countries.
Summary for chlorpheniramine polistirex; codeine polistirex
International Patents: | 21 |
US Patents: | 2 |
Tradenames: | 3 |
Applicants: | 3 |
NDAs: | 3 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for chlorpheniramine polistirex; codeine polistirex |
DailyMed Link: | chlorpheniramine polistirex; codeine polistirex at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for chlorpheniramine polistirex; codeine polistirex
Generic Entry Date for chlorpheniramine polistirex; codeine polistirex*:
Constraining patent/regulatory exclusivity:
Dosage:
SUSPENSION, EXTENDED RELEASE;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for chlorpheniramine polistirex; codeine polistirex
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lannett Co Inc | CODEPREX | chlorpheniramine polistirex; codeine polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 021369-001 | Jun 21, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Fisons | PENNTUSS | chlorpheniramine polistirex; codeine polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 018928-001 | Aug 14, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Tris Pharma Inc | TUZISTRA XR | chlorpheniramine polistirex; codeine polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 207768-001 | Apr 30, 2015 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Tris Pharma Inc | TUZISTRA XR | chlorpheniramine polistirex; codeine polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 207768-001 | Apr 30, 2015 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for chlorpheniramine polistirex; codeine polistirex
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Fisons | PENNTUSS | chlorpheniramine polistirex; codeine polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 018928-001 | Aug 14, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for chlorpheniramine polistirex; codeine polistirex
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Taiwan | 200812649 | Modified release formulations containing drug-ion exchange resin complexes | ⤷ Try a Trial |
Austria | E536867 | ⤷ Try a Trial | |
Spain | 2396039 | ⤷ Try a Trial | |
Denmark | 2428205 | ⤷ Try a Trial | |
European Patent Office | 2018160 | FORMULATIONS A LIBERATION MODIFIEE CONTENANT DES COMPLEXES MEDICAMENT - RESINE ECHANGEUSE D'IONS (MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES) | ⤷ Try a Trial |
South Korea | 20080108520 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG - ION EXCHANGE RESIN COMPLEXES | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2007109104 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |